Suchergebnisse - "Wu, Lung-Sheng"

PubPharm (6)

1

Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis : A Population-Based Cohort Study and Meta-Analysis

enthalten in: Cardiovascular drugs and therapy | 2021

von See, L. | Lee, H. | Chao, T. | +8

2

Oral Anticoagulants and Antiplatelet Agents in Patients With Atrial Fibrillation and Concomitant Critical Limb Ischemia : A Nationwide Cohort Study

enthalten in: The Canadian journal of cardiology | 2021

von Lee, H. | Chan, Y. | Li, P. | +8

3

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

enthalten in: Cardiovascular diabetology | 2020

von Chan, Y. | Lee, H. | Li, P. | +8

4

The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation

enthalten in: International journal of cardiology | 2018

von Lee, H. | Chan, Y. | Tu, H. | +5

5

Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation

enthalten in: Journal of the American Heart Association | 2018

von Chan, Y. | See, L. | Tu, H. | +7

6

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation

enthalten in: Journal of the American College of Cardiology | 2016

von Chan, Y. | Kuo, C. | Yeh, Y. | +5

CommentIn: J Am Coll Cardiol. 2016 Sep 27;68(13):1402-1403. - PMID 27659461

1
[1]